Curaleaf Holdings, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Boris Alexis Jordan
- Full Time Employees
- 5,554
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 290 Harbor Drive Stamford CT United States of America 06902
- IPO Date
- Oct 29, 2018
- CIK
- 0001756770
- Website
- curaleaf.com
- Similar Companies
- Business
- Curaleaf Holdings, Inc. is a leading vertically integrated cannabis company engaged in the cultivation, processing, manufacturing, and distribution of cannabis products primarily in the United States, with expanding international operations. Founded in 2010 and headquartered in New York City, Curaleaf operates across approximately 17 states in the U.S., with a substantial footprint consisting of 151 dispensaries, 19 cultivation sites, and 20 manufacturing facilities. The company's product portfolio includes cannabis flower, pre-rolls, flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing and dabbing, including pre-filled cartridges and disposable pens, as well as edibles, tinctures, topicals, mints, lozenges, capsules, and hemp-derived products such as cannabidiol (CBD) and cannabigerol (CBG) items. Curaleaf serves both medical and adult-use markets through its diverse brands including Curaleaf, Select, Grassroots, JAMS, Find, The Hemp Company, and Zero Proof. In the last 1-2 years, Curaleaf has pursued aggressive expansion and innovation strategies. The company launched a new pre-roll brand and expanded its hemp-derived beverage line with new products including Select Zero Proof seltzers and The Hemp Co. hemp-derived THC seltzers distributed in multiple states through major retailers such as Total Wine. Curaleaf also introduced the Reef flower brand in Florida and expanded retail operations with new dispensaries opening in key growth states such as Florida and New York. Financially, Curaleaf secured a $40 million revolving credit facility with a major commercial regional bank, marking a significant milestone in cannabis company financing. The company’s strategic direction focuses on organic growth, margin optimization, international expansion, and deployment of advanced technology platforms such as ACE for operational improvements. Curaleaf’s recent initiatives reflect its positioning as the largest cannabis company by revenue in the U.S., operating in highly regulated populous states with an emphasis on product innovation and quality assurance. Curaleaf’s business model relies on vertical integration, controlling its supply chain from cultivation through retail, ensuring product quality and cost efficiency. It targets a broad consumer base comprising medical patients and recreational users, catering to diverse preferences through a wide range of premium cannabis-derived products. The company is known for its rigorous safety, efficacy, and consistency standards upheld through extensive research and development. Curaleaf continues to expand its retail footprint and manufacturing capacity to consolidate leadership in the multi-state operator (MSO) cannabis market while advancing its hemp division and international sales. Its operations emphasize compliance with regulatory frameworks and fostering industry education and advocacy in the evolving cannabis sector. Curaleaf employs approximately 5,500 staff and reports annual revenues of approximately $1.3 billion, maintaining strong cash flow generation despite market challenges. This description reflects Curaleaf Holdings, Inc.’s current industry standing, business activities, product range, geographic presence, and recent strategic developments as of late 2025.
Company News
Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
Curaleaf Continues Florida Expansion with Port Orange Dispensary Opening
Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal
Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s What Happened
Curaleaf Relocates Gettysburg Dispensary to York, Bringing Care Closer to Patients in South Central Pennsylvania
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Curaleaf Continues Florida Expansion with Wellington Dispensary Opening
The Deep Value Play for Growth Investors Isn't Artificial Intelligence, It's This Forgotten Industry
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher
Head to Head Survey: Curaleaf (OTCMKTS:CURLF) versus LogicMark (OTCMKTS:LGMKD)
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Curaleaf Files Update to Offering Circular
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
Curaleaf Files Update to Offering Circular
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
Curaleaf raises Aurora Cannabis offer by 25%
Curaleaf Enhances Offer to Acquire Aurora Cannabis
Curaleaf (OTCMKTS:CURLF) Shares Gap Down – What’s Next?
Curaleaf Marks Seven Years and $600,000 Donated For Breast Cancer Action Month
Curaleaf to Report Third Quarter 2026 Financial and Operational Results